Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 12,453 | 16,653 | 29,597 | 18,390 | 20,610 |
| Cost of Goods | 857 | 1,201 | 1,342 | 2,588 | 3,312 |
| Gross Profit | 11,596 | 15,452 | 28,255 | 15,802 | 17,298 |
| Operating Expenses | 12,222 | 17,547 | 25,057 | 22,976 | 23,738 |
| Operating Income | 231 | -1,894 | 3,540 | -6,586 | -6,128 |
| Interest Expense | 7,134 | 5,492 | 7,383 | 5,013 | 3,101 |
| Other Income | -580 | 962 | 51 | 1,034 | -6,692 |
| Pre-tax Income | -7,483 | -6,424 | -3,792 | -10,565 | -15,921 |
| Income Tax | 9 | 29 | -59 | 60 | 25 |
| Net Income Continuous | -7,492 | -6,453 | -3,733 | -10,625 | -15,946 |
| Net Income | $-7,492 | $-6,453 | $-3,733 | $-10,625 | $-15,946 |
| EPS Basic Total Ops | -0.12 | -0.10 | -0.07 | -0.21 | -0.32 |
| EPS Basic Continuous Ops | -0.12 | -0.10 | -0.07 | -0.21 | -0.32 |
| EPS Diluted Total Ops | -0.12 | -0.10 | -0.07 | -0.21 | -0.32 |
| EPS Diluted Continuous Ops | -0.12 | -0.10 | -0.07 | -0.21 | -0.32 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.10 | -0.07 | -0.21 | -0.32 |
| EBITDA(a) | $830 | $-1,164 | $6,140 | $-4,718 | $-4,259 |